Wockhardt News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.09.16	Drugmakers including Cipla, Wockhardt pledge to clean up antibiotic factories, curb overuse (Reuters)
28.01.16	U.S. regulator finds Indian drug maker Wockhardt hid failed tests (Reuters)
15.01.16	Wockhardt slumps after FDA criticisms of new drug plant (Reuters)
29.05.15	Wockhardt hopes to resolve FDA ban on two plants in FY16 (Reuters)
28.04.15	Wockhardt to recall some drugs made in India after U.S. FDA concerns (Reuters)
26.02.15	Wockhardt says FDA raises new concerns about Waluj plant (Reuters)
03.11.14	Wockhardt Q2 profit plunges on U.S. export bans (Reuters)
10.09.14	Wockhardt shares gain on unit merger plan (Reuters)
12.08.14	Wockhardt Q1 net profit falls 94 percent on plant bans (Reuters)
03.06.14	FDA criticises quality control, training at Wockhardt U.S. plant (Reuters)
27.05.14	Wockhardt says FDA inspected U.S. unit in March quarter (Reuters)
26.05.14	Wockhardt Q4 profit down 78 percent on import bans (Reuters)
15.05.14	Wockhardt recalls over 109,000 bottles of hypertension drug in U.S. (Reuters)
29.04.14	Wockhardt denies media report on asset sale talks (Reuters)
28.04.14	Wockhardt says Himachal regulator lifts drug ban (Reuters)
23.04.14	Wockhardt says Himachal Pradesh drug regulator suspends product (Reuters)
10.02.14	Wockhardt third-quarter profit falls 29 percent (Reuters)
19.12.13	Wockhardt surges on listing of unit in Europe (Reuters)
27.11.13	Wockhardt hit by FDA alert on another plant (Reuters)
07.11.13	Wockhardt rallies; NSE raises daily price limit (Reuters)
25.10.13	Wockhardt profit dives on U.S., UK regulator demands (Reuters)
22.10.13	Third Wockhardt plant hit by export restrictions (Reuters)
14.10.13	Wockhardt falls 5 percent after UK regulator says factory is non compliant (Reuters)
25.07.13	Wockhardt to appoint consultant at plant for U.S. FDA compliance (Reuters)
24.07.13	Wockhardt plunges after FDA warning, downgrade (Reuters)
11.07.13	British drug regulator recalls Wockhardt medicines (Reuters)
11.06.13	Wockhardt shares slump; sales of pain reliever suspended (Reuters)
24.05.13	Wockhardt slumps for second day on U.S. FDA import alert (Reuters)
23.05.13	Wockhardt says FDA alert affects potential sales of $100 million (Reuters)
23.05.13	Wockhardt shares drop 20 percent after FDA import alert (Reuters)
16.05.13	MSCI India index adds four stocks, including Wockhardt (Reuters)
26.03.13	BofA-Merrill initiates Wockhardt with 'buy' (Reuters)
28.08.12	Wockhardt, SKS Microfinance drop on trade settlement by BSE (Reuters)
20.08.12	Wockhardt gets U.S. nod for Parkinson's generic (Reuters)
16.08.12	Wockhardt: from debt debacle to stock rocket (Reuters)
17.05.12	Ind-Swift, Wockhardt launch generic Lipitor in UK (Reuters)
23.03.12	Wockhardt recalls wrong-strength painkiller in UK (Reuters)
02.08.11	Danone to buy Wockhardt nutrition assets in India (Reuters)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Wockhardt

Aktien Top/Flop

Meistgelesene Nachrichten